stockrowElevance Health, Inc.
ELV Healthcare Healthcare Plans
Elevance Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $199.1 billion, up 12.5% from fiscal 2024.
- Revenue
- +1.42%
- EPS
- +17.9%
- Free cash flow
- +29.0%
- Total debt
- −3.65%
Quarter to September 2026, against a year earlier
Follow ELV
Alert me
Elevance Health, Inc. (ELV) Net income
Elevance Health, Inc.'s net income for fiscal 2025 was $5.7B, down 5.19% from $6.0B in fiscal 2024. Over the twelve months to 30 September 2026 it was $5.1B. Over the past ten years it has ranged from $2.5B (fiscal 2016) to $6.1B (fiscal 2021); the current reading is higher than 64% of that period. Elevance Health, Inc. ranks 4th of 12 Healthcare Plans companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $5.7B | (5.19%) |
| FY2024 | $6.0B | (0.33%) |
| FY2023 | $6.0B | 1.75% |
| FY2022 | $5.9B | (4.24%) |
| FY2021 | $6.1B | 34.49% |
| FY2020 | $4.6B | (4.89%) |
| FY2019 | $4.8B | 28.19% |
| FY2018 | $3.8B | (2.42%) |
| FY2017 | $3.8B | 55.59% |
| FY2016 | $2.5B | (3.52%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $1.3B | (7.63%) |
| Jun 2026 | $1.5B | (17.39%) |
| Mar 2026 | $1.8B | 222.34% |
| Dec 2025 | $546.0M | (54.00%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $16.7B |
| CVS CVS Health Corporation compare | $11.0B |
| CI Cigna Group compare | $6.7B |
| ELV Elevance Health, Inc. | $5.1B |
| CNC Centene Corporation compare | $1.5B |
| HUM Humana Inc. compare | $1.3B |
| OSCR Oscar Health, Inc. compare | $855.7M |
| PGNY Progyny, Inc. compare | $91.0M |
| MOH Molina Healthcare, Inc compare | −$48.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ELV
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement